1030-33-7 Usage
General Description
2-Phenyl-imidazo[1,2-a]pyridine-7-carboxylic acid methyl ester, also known as PI-7-C, is a chemical compound with potential applications in drug development, particularly in the field of medicinal chemistry. It is a methyl ester derivative of 2-phenyl-imidazo[1,2-a]pyridine-7-carboxylic acid, which is a heterocyclic compound with a fused imidazole and pyridine ring system. PI-7-C has been studied for its potential as a ligand for GABA receptors and as an anticonvulsant, as well as for its ability to modulate neurotransmitter release. Additionally, it has also been investigated for its potential anti-inflammatory and analgesic properties. Overall, PI-7-C is a versatile compound with a wide range of potential pharmacological activities, making it an interesting target for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1030-33-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,3 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1030-33:
(6*1)+(5*0)+(4*3)+(3*0)+(2*3)+(1*3)=27
27 % 10 = 7
So 1030-33-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N2O2/c1-19-15(18)12-7-8-17-10-13(16-14(17)9-12)11-5-3-2-4-6-11/h2-10H,1H3
1030-33-7Relevant articles and documents
Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents
Ye, Zhiwen,Liu, Chunxia,Zou, Feng,Cai, Yan,Chen, Bin,Zou, Yuxing,Mo, Jiaxian,Han, Ting,Huang, Wenlong,Qiu, Qianqian,Qian, Hai
, (2020/06/19)
Free fatty acid receptor 1 (FFA1 or GPR40) has been studied for many years as a target for the treatment of type 2 diabetes mellitus. In order to increase potency and reduce hepatotoxicity, a series of novel compounds containing imidazo[1,2-a]pyridine sca
NOVEL IMIDAZOPYRIDINES
-
Page/Page column 12-13, (2011/04/18)
The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically accept
